Thiobutabarbital
From Self-sufficiency
100px | |
Systematic (IUPAC) name | |
---|---|
5-sec-butyl-5-ethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione | |
Identifiers | |
CAS Number | 2095-57-0 |
ATC code | none |
PubChem | CID 3032373 |
Synonyms | Thiobutabarbital, Inactin, Brevinarcon, 5-sec-Butyl-5-ethyl-2-thiobarbituric acid |
Chemical data | |
Formula | C10H16N2O2S |
Molar mass | 228.312 g/mol[[Script error: No such module "String".]] |
Thiobutabarbital (Inactin, Brevinarcon) is a short-acting barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant and hypnotic effects, and is still used in veterinary medicine for induction in surgical anaesthesia [1]
References
- ↑ Rieg T, Richter K, Osswald H, Vallon V. Kidney function in mice: thiobutabarbital versus alpha-chloralose anesthesia. Naunyn Schmiedebergs Archives of Pharmacology. 2004 Oct;370(4):320-3.
This pharmacology-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Pharmacology stubs
- Thiobarbiturates
- 2Fix